Corticosteroid therapy in rheumatoid arthritis
References (119)
- et al.
Tissue effects of glucocorticoids
American Journal of Medicine
(1972) - et al.
Reversion and reconversion rate of ‘tuberculin’ skin reactions in correction with the use of prednisone
Diseases of the Chest
(1960) Genetics of glucocorticoid receptors
Molecular and Cellular Endocrinology
(1986)- et al.
Hydrocortisone-mediated inhibition of monocyte antigen presentation: Dissociation of inhibiting effect and expression of DR antigens
Cell Immunology
(1984) - et al.
Increased expression of JLA-DR antigens in hydrocortisone-treated monocytes
Cell Immunology
(1984) - et al.
Activated human T cells can present antigens but cannot present soluble antigens
Cell Immunology
(1985) - et al.
Local corticosteroid injection treatment in rheumatic disorders
German Arthritis & Rheumatism
(1981) - et al.
Corticosteroid-induced vasoconstriction studies by Xenon 133 clearance
Journal of Investigational Dermatology
(1973) The regulation of lipomodulin, a phopholipase inhibitory protein in rabbit neutrophils by phosphorylation
Journal of Biological Chemistry
(1981)- et al.
Effect of anti-inflammatory drugs and agents that elevate cyclic AMP on the release of toxic oxygen metabolites by phagocytes
Clinical Immunology and Immunopathology
(1978)
The effects of betamimetics and glucocorticoids on fetal vascular prostacyclin and platelet thromboxane synthesis in humans
Prostaglandin Leukotrienes Medicine
(1984)
Glucocorticoid receptors in subpopulations of human lymphocytes defined by monoclonal antibodies
Cell Immunology
(1987)
Chemical studies of the suprarenal cortex II. The identification of a substance which possesses the qualitative action of cortin: its conversion into a diketone closely related to androstenedione
Journal of Biological Chemistry
(1936)
The chemistry of crystalline substances isolated from the suprarenal gland
Journal of Biological Chemistry
(1936)
The hormones of the adrenal cortext
Vitamins and Hormones
(1943)
Effect of corticosteroids and splenectomy on the immunoclearance and destruction of erythrocytes
Journal of Clinical Investigations
(1973)
Repeated corticosteroid injections into knee joints
Rheumatology and Rehabilitation
(1977)
General presence of glucocorticoid receptors in mammalian tissues
Endocrinology
(1974)
Value of monitoring plasma salicylate levels in treating juvenile rheumatoid arthritis: observations in 42 cases
Archives of Disease in Childhood
(1978)
Disorganisation of the knees following intraarticular hydrocortisone injection
Journal of Bone & Joint Surgery
(1969)
Rheumatoid patients after 5 or more years of corticosteroid therapy: a comparison analysis of 183 cases
Annals of Internal Medicine
(1961)
Control of cachetin (TWF) synthesis mechanisms of endotoxin resistance
Science
(1986)
A polypeptide causing the antiphospholipase effects of glucocorticoids
Nature
(1980)
Clinical measurements of the anti-inflammatory effects of salicylates in rheumatoid arthritis
British Medical Journal
(1967)
Adverse effects of phenobarbital on corticosteroid metabolism in asthmatics
New England Journal of Medicine
(1972)
Effect of enzyme induction on metabolism of prednisolone
Annals of Rheumatic Disability
(1976)
Effects of corticosteroids on immunity in man I. Decreased serum IgG concentrations caused by 3 or 5 days of high doses of methylprednisolone
Journal of Clinical Investigation
(1973)
Corticosteroids in rheumatoid arthritis: is a trial of their disease modifying potential feasible?
Annals of the Rheumatic Diseases
(1986)
Glucocorticoids in the management of vasculitis—a double edged sword?
Journal of Rheumatology
(1988)
Non-association of adrenocorticosteroid therapy and peptic ulcer
New England Journal of Medicine
(1976)
Glucocorticoids inhibit expression of Fc receptors on the human granulocytic cell line. HL-60
Nature
(1979)
Pathophysiology of vasculitis
Multiple mechanisms of B cell immuno-regulation in man after administration of in-vivo corticosteroids
Journal of Immunology
(1984)
Glucocorticoids and the gastrointestinal tract: current status
Gut
(1970)
Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections
New England Journal of Medicine
(1974)
Small doses of prednisolone in the treatment of rheumatoid arthritis
Annals of the Rheumatoid Diseases
(1964)
Measurement of clinical response to anti-inflammatory drugs in rheumatoid arthritis
Quarterly Journal of Medicine
(1973)
Studies on steroid fever II. Pyrogenic and anti-pyrogenic activity in vitro of some endogenous steroids of man
Journal of Clinical Investigation
(1970)
Interleukin 1
Review of Infectious Diseases
(1984)
Changes in connective tissue reaction induced by cortisone
Annals of Internal Medicine
(1952)
Multicentre controlled trial comparing cortisone acetate and acetylsalicylic acid in the long term treatment of rheumatoid arthritis
Annals of the Rheumatic Diseases
(1957)
The steroid and thyroid hormone receptor superfamily
Science
(1988)
Mechanisms of corticosteroid action on lymphocyte subpopulations. 1: Redistribution of circulating T & B lymphocytes to the bone marrow
Immunology
(1975)
Glucocorticoid therapy: mechanisms of action and clinical considerations
Annals of Internal Medicine
(1976)
Conversion from daily to alternate daily corticosteroids in rheumatoid arthritis
Annals of the Rheumatic Diseases
(1982)
Intra-synovial injection of steroids: Uses and abuses
Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation
Nature
(1979)
Realistic guideline of corticosteroid therapy in rheumatic disease
Glucocorticoid-induced inhibition of T cell growth factor production. 1: The effect on mitogen-induced lymphocyte proliferation
Journal of Immunology
(1979)
Complement and immunoglobulin stimulate superoxide production by human leukocytes independently of phagocytosis
Journal of Clinical Investigations
(1975)
Cited by (9)
Long-term prednisone in doses of less than 5 mg/day for treatment of rheumatoid arthritis: Personal experience over 25 years
2011, Clinical and Experimental RheumatologyEfficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: A randomised, double-blind, placebo controlled withdrawal clinical trial
2009, Annals of the Rheumatic DiseasesLow dose corticosteroid treatment in RA - Inhibition of progression versus risk of steroid osteoporosis
2001, Zeitschrift fur RheumatologieRheumatology: 8. Advanced therapy
2000, CMAJ. Canadian Medical Association Journal
Copyright © 1990 Published by Elsevier Ltd.